
==== Front
Nucleic Acids ResNucleic Acids ResnarnarNucleic Acids Research0305-10481362-4962Oxford University Press 1763631210.1093/nar/gkm526ChemistryDetection of phosphodiester adducts formed by the reaction of benzo[a]pyrene diol epoxide with 2′-deoxynucleotides using collision-induced dissociation electrospray ionization tandem mass spectrometry Gaskell Margaret Kaur Balvinder Farmer Peter B. Singh Rajinder *Cancer Biomarkers and Prevention Group, Biocentre, University of Leicester, University Road, Leicester, LE1 7RH, UK*To whom correspondence should be addressed:+44 0 116 2231827 +44 0 116 2231840 rs25@le.ac.uk8 2007 18 7 2007 18 7 2007 35 15 5014 5027 24 5 2007 22 6 2007 © 2007 The Author(s)2007This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.In this study, we investigated the products formed following the reaction of benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (B[a]PDE) with 2′-deoxynucleoside 3′-monophosphates. The B[a]PDE plus 2′-deoxynucleotide reaction mixtures were purified using solid phase extraction (SPE) and subjected to HPLC with fluorescence detection. Fractions corresponding to reaction product peaks were collected and desalted using SPE prior to analysis for the presence of molecular ions corresponding to m/z 648, 632, 608 and 623 [M−H]− consistent with B[a]PDE adducted (either on the base or phosphate group) 2′-deoxynucleotides of guanine, adenine, cytosine and thymine, respectively, using LC-ESI-MS/MS collision-induced dissociation (CID). Reaction products were identified having CID product ion spectra containing product ions at m/z 452, 436 and 412 [(B[a]Ptriol+base)−H]−, resulting from cleavage of the glycosidic bond between the 2′-deoxyribose and base, corresponding to B[a]PDE adducts of guanine, adenine and cytosine, respectively. Further reaction products were identified having unique CID product ion spectra characteristic of B[a]PDE adduct formation with the phosphate group of the 2′-deoxynucleotide. The presence of product ions at m/z 399 and 497 were observed for all four 2′-deoxynucleotides, corresponding to [(B[a]Ptriol+phosphate)−H]− and [(2′-deoxyribose+phosphate+B[a]Ptriol)−H]−, respectively. In conclusion, this investigation provides the first direct evidence for the formation of phosphodiester adducts by B[a]PDE following reaction with 2′-deoxynucleotides.
==== Body
INTRODUCTION
A potential site in DNA for the interaction of genotoxic species is the phosphodiester linkages between the 2′-deoxynucleosides, which constitute the sugar-phosphate backbone of DNA, resulting in esterification of the phosphate group and formation of phosphotriester adducts. The properties of phosphotriester adducts have been extensively studied using simple alkylating agents as model compounds showing that they represent long lived biomarkers of exposure (1–3). In contrast the potential of polycyclic aromatic hydrocarbons (PAHs) to form phosphodiester adducts with 2′-deoxynucleotides as well as phosphotriester adducts in DNA has not been clearly ascertained (4).

Studies involving human fibroblast cells and rodents have shown that alkyl phosphotriester adducts are more stable to DNA repair when compared to base adducts (5–7). For alkylating agents it has been shown that the relative abundance of phosphotriester DNA adducts formed depends on the chemical nature of the genotoxic species (1,3,8). The biological consequences of alkyl phosphotriester adducts is not fully understood, though they are chemically stable under physiological conditions and may potentially alter the binding/function of proteins such as DNA repair or replication enzymes (1,9). To date, the compounds investigated for the formation of phosphodiester or phosphotriester adducts include alkylating agents, such as dialkylsulphates, alkyl methanesulphonates and N-nitroso compounds cyanoethylene oxide, cyclophosphamide and phenyl glycidyl ether (10–16).

PAHs of which benzo[a]pyrene (B[a]P) is a well-studied example, represent an important class of compounds found as ubiquitous environmental pollutants or in certain occupational settings (17,18). PAHs are produced by the incomplete combustion of fossil fuels and the chargrilling of food as well as being present in automobile exhaust and cigarette smoke (19). PAHs have been shown to be carcinogenic in animals and potentially carcinogenic to humans (20–22). Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (B[a]PDE) is the reactive species formed by the cytochrome P450 mediated metabolism of B[a]P (23,24). The reaction of B[a]PDE via a B[a]Ptriol carbocation intermediate with purine and pyrimidine bases present in DNA has been well characterized, the predominant product formed is by reaction with the exocyclic amino group of guanine and to a lesser extent with the exocyclic amino groups of adenine and cytosine (25–27). The base adducts formed by B[a]PDE exist as diastereoisomers following cis or trans addition at C-10 of the hydrocarbon and studies show that the (+)-anti-B[a]PDE isomer with the 7R,8S,9S,10R configuration has greatest carcinogenic activity in vivo (28). B[a]PDE produces concentration-dependent strand breaks in DNA in vitro with the fragmentation of the DNA being attributable to the formation of a phosphotriester adduct rather than a base adduct. A mechanism for DNA strand scission has been proposed that involves the C-9 hydroxyl group of B[a]PDE attacking the phosphotriester group and the formation of a cyclic triester intermediate as shown in Scheme 1 (29).

The technique of collision-induced dissociation (CID) tandem mass spectrometry provides structural information, which is important since both the base and phosphodiester adducted 2′-deoxynucleotides have the same molecular mass. This approach has been used to characterize the phosphodiester adducts formed by phenyl glycidal ether and ethylating agents (11,16). We investigated the formation of phosphodiester adducts resulting from the reaction of B[a]PDE with 2′-deoxynucleotides using negative electrospray ionization tandem mass spectrometry CID.

EXPERIMENTAL PROCEDURES
Chemicals
(±)-Anti-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (B[a]PDE) was purchased from the NCI Chemical Carcinogen Repository, Midwest Research Institute (Kansas City, Missouri, USA). The 2′-deoxynucleoside 3′-monophosphates and TRIS base were purchased from Sigma (Poole, Dorset, UK). All other reagents (analytical grade), HPLC (fluorescence) grade methanol, were purchased from Fisher Scientific (Loughborough, UK). HPLC grade water, 18.2 MΩ output quality was obtained from Maxima purification equipment (Elga, High Wycombe, UK).

Caution B[a]PDE is a mutagen and carcinogen. Protective clothing should be worn and appropriate safety procedures followed when working with the compound.

Reaction of 2′-deoxynucleotides with B[a]PDE
The four 2′-deoxynucleosides 3′-monophosphates (1 mg dissolved in 750 µl of 0.1 M TRIS base, pH 7.0) were each incubated with B[a]PDE (250 µg; 1 μg/µl dissolved in methanol) for 18 h at 37°C. Unreacted starting material containing 2′-deoxynucleosides 3′-monophosphates was removed by subjecting the reaction mixtures to solid phase extraction using Oasis HLB columns (1 cc, 30 mg, Waters Ltd, Elstree, UK) connected to a vacuum manifold (Phenomenex, Macclesfield, UK) maintained at a vacuum of 5 mmHg. The columns were initially conditioned with 1.0 ml of methanol followed by 1.0 ml of HPLC grade water. The reaction mixtures were then loaded onto the columns and washed with 1.0 ml of 5 : 95 methanol/water (v/v). The reaction products were eluted from the columns with 2.0 ml of methanol. Samples were dried to completeness using a centrifugal vacuum evaporator (Speedvac, Savant, Farmingdale, NY, USA) and resuspended in 400 μl of 10 : 90 acetonitrile/HPLC grade water (v/v). Samples (20–50 μl aliquots) were analysed by HPLC-fluorescence detection using a Waters 2690 Separations Module coupled to a Waters 470 fluorescence detector (excitation 332 nm, emission 388 nm) connected to a Phenomenex Synergi Fusion-RP 80 C18 column (4 µm, 250 × 4.6 mm) and a Synergi Fusion-RP 80 C18 (4 µm, 4 × 3.0 mm) guard column. The column was eluted using a gradient of 0.05 M potassium phosphate buffer, pH 7.2 (solvent A) and acetonitrile (solvent B) at a flow of 1.0 ml/min with 0 min–10%B, 60 min–40%B, 65 min–80%B, 67 min–10% B, 70 min–10%B.

Desalting of HPLC fractions
Collected HPLC product fractions were pooled together, evaporated to dryness and then dissolved in 1.0 ml of 5 : 95 methanol/water (v/v). The purified HPLC fractions were subjected to solid phase extraction using Oasis HLB columns (1 cc, 30 mg) connected to a vacuum manifold maintained at a vacuum of 5 mmHg. The columns were initially conditioned with 1.0 ml of methanol followed by 1.0 ml of HPLC grade water. The purified HPLC fractions were then loaded onto the columns and washed with 1.0 mL of HPLC grade water. The reaction products were eluted from the columns with two 750 μl aliquots of methanol, evaporated to dryness using a centrifugal vacuum evaporator and redissolved in 400 μl of methanol/HPLC grade water (20:80, v/v).

Mass spectrometric analysis
The LC-MS/MS consisted of a Waters Alliance 2695 separations module with a 100 μl injection loop connected to a Micromass Quattro Ultima Pt. (Micromass, Waters Ltd, Manchester, UK) tandem quadrupole mass spectrometer with an electrospray interface. The temperature of the electrospray source was maintained at 110°C and the desolvation temperature at 350°C. Nitrogen gas was used as the desolvation gas (650 l/h) and the cone gas was set to zero. The capillary voltage was set at 3.00 kV. The cone and RF1 lens voltages were 42 and 25 V, respectively.

The mass spectrometer was tuned by using a dGp standard solution (10 pmol/μl) dissolved in methanol/HPLC grade water (45:65, v/v) introduced by continuous infusion at a flow rate of 10 μl/min with a Harvard model 22 syringe pump (Havard Apparatus Ltd, Edenbridge, UK). Initial analysis of the reaction products was performed using continuous infusion and full scan negative ESI-MS over the m/z range from 60 to 800, following a 1:10 dilution with methanol/HPLC grade water (45:65, v/v) of each of the purified reaction products.

A 20 μl undiluted aliquot of each purified reaction product was injected onto a HyPurity C18 (3 μm, 150 × 2.1 mm) column (Thermo Electron Corporation, Runcorn, UK) connected to a Uniguard HyPurity C18 (3 μm, 10 × 2.1 mm) guard cartridge attached to KrudKatcher (Phenomenex) disposable pre-column (5 μm) filter. The column was eluted isocratically with solvent A, methanol/HPLC grade water (45:65, v/v) at a flow rate of 120 μl/min for 45 min. It was then washed with solvent B, methanol at a flow rate of 200 μl/min for 10 min and then equilibrated to starting conditions with solvent A at a flow rate of 120 μl/min for 15 min. The collision gas was argon (indicated cell pressure 3.0–3.5 × 10−3 mbar) and the collision energy set at 21 eV. The dwell time was set to 200 ms and the resolution was one m/z unit at peak base. The samples were analysed in negative electrospray ionization (ESI) mode MS/MS CID for the deprotonated molecular ion [M−H]− for each B[a]PDE adducted 2′-deoxynucleotide: 2′-deoxyguanosine 3′-monophosphate (dGp) [C30H28N5O10P-H]−
m/z 648.15; 2′-deoxyadenosine 3′-monophosphate (dAp) [C30H28N5O9P−H]−
m/z 632.16; 2′-deoxycytidine 3′-monophosphate (dCp) [C29H28N3O10P-H]− 608.14 and thymidine 3′-monophosphate (Tp) [C30H29N2O11P-H]−
m/z 623.14. The mass spectral data was acquired in continuum mode and processed using MassLynx version 4.0 (Micromass, Waters Ltd).

RESULTS
HPLC-fluorescence analysis of the B[a]PDE plus 2′-deoxynucleotide reaction products
The reaction mixtures for the four different 2′-deoxynucleotides and B[a]PDE were initially subjected to solid phase extraction to remove any unreacted 2′-deoxynucleoside 3′-monophosphates, followed by separation using HPLC with fluorescence detection. The typical HPLC-fluorescence chromatogram of a control reaction mixture containing only B[a]PDE and 0.1 M TRIS base pH 7.0 buffer incubated at 37°C for 18 h and subjected to solid phase extraction is shown in Figure 1. The typical HPLC-fluorescence chromatograms for 2′-deoxynucleotides plus B[a]PDE reaction mixtures are shown in Figures 2A, 3A, 4A and 5A. Fractions corresponding to the peaks that eluted before retention time 35 min, since these were unique to the reaction mixtures and not present in the control reaction mixture, were collected, pooled and evaporated to dryness and then subjected to a further purification by solid phase extraction (to remove any salts) prior to analysis by continuous infusion full scan negative ESI-MS to determine the presence of the deprotonated molecular [M−H]− ion for each adducted 2′-deoxynucleotides. Each fraction was then further characterized using LC-ESI-MS/MS CID.
Figure 1. HPLC-fluorescence chromatogram of a reaction mixture containing (±)-anti-B[a]PDE (250 μg) and 0.1 M TRIS base pH 7.0 buffer incubated at 37°C for 18 h and subjected to solid phase extraction. The analysis was performed using gradient elution with 0.05 M potassium phosphate buffer, pH 7.2 (solvent A) and acetonitrile (solvent B) at a flow of 1 ml/min (* = refer to Figures 2A, 4A and 5A).


Figure 2. HPLC-fluorescence chromatogram of the reaction of B[a]PDE (250 μg) with dGp (1 mg) following gradient elution with 0.05 M potassium phosphate buffer, pH 7.2 (solvent A) and acetonitrile (solvent B) at a flow of 1 ml/min (A) Typical negative ESI LC-MS/MS CID product ion spectra for fractions 1 and 2 corresponding to phosphodiester adducts (B) and fraction 3 corresponding to base adduct (C). Both spectra were obtained from the molecular ion [M−H]− at m/z 648 following isocratic elution with methanol/HPLC grade water (45:65, v/v) at a flow rate of 120 μl/min and collision energy of 21 eV [* = peaks present in control reaction mixture (Figure 1)].


Figure 3. HPLC-fluorescence chromatogram of the reaction of B[a]PDE (250 μg) with dAp (1 mg) following gradient elution with 0.05 M potassium phosphate buffer, pH 7.2 (solvent A) and acetonitrile (solvent B) at a flow of 1 ml/min (A). Typical negative ESI LC-MS/MS CID product ion spectra for fractions 1, 2 and 3 corresponding to phosphodiester adducts (B) fraction 4 corresponding to base adduct (C). Both spectra were obtained from the molecular ion [M−H]− at m/z 632 following isocratic elution with methanol/HPLC grade water (45:65, v/v) at a flow rate of 120 μl/min and collision energy of 21 eV.


Figure 4. HPLC-fluorescence chromatogram of the reaction of B[a]PDE (250 μg) with dCp (1 mg) following gradient elution with 0.05 M potassium phosphate buffer, pH 7.2 (solvent A) and acetonitrile (solvent B) at a flow of 1 ml/min (A). Typical negative ESI LC-MS/MS CID product ion spectra for fractions 1, 2 and 3 corresponding to phosphodiester adducts (B) fraction 4 corresponding to base adduct. (C) Both spectra were obtained from the molecular ion [M−H]− at m/z 608 following isocratic elution with methanol/HPLC grade water (45:65, v/v) at a flow rate of 120 μl/min and collision energy of 21 eV [* = peaks present in control reaction mixture (Figure 1)].


Figure 5. HPLC-fluorescence chromatogram for the reaction of B[a]PDE (250 μg) with Tp (1 mg) following gradient elution with 0.05 M potassium phosphate buffer, pH 7.2 (solvent A) and acetonitrile (solvent B) at a flow of 1 ml/min (A). Typical negative ESI LC-MS/MS CID product ion spectrum for fractions 1 and 2 corresponding to phosphodiester adducts (B). The spectrum was obtained from the molecular ion [M−H]− at m/z 623 following isocratic elution with methanol/HPLC grade water (45:65, v/v) at a flow rate of 120 μl/min and collision energy of 21 eV [* = peaks present in control reaction mixture (Figure 1)].



Reaction of 2′-deoxynucleotides with B[a]PDE—phophodiester adducts
For each 2′-deoxynucleotide, the phophodiester adducts eluted before the corresponding base adducts following analysis by HPLC-fluorescence and then by LC-ESI-MS/MS CID. Typically, the LC-ESI-MS/MS retention times ranged from 7 to 12 min using the microbore C18 column (data not shown). The LC-ESI-MS/MS CID product ion spectra for each adducted 2′-deoxynucleotide are shown in Figures 2B, 3B, 4B and 5B. Two distinct product ions at m/z 399 and 497 were observed corresponding to the [(B[a]Ptriol+phosphate)−H]− and [(2′-deoxyribose+phosphate+B[a]Ptriol)−H]−, respectively, resulting from the fragmentation of the precursor molecular ion of each of the four adducted 2′-deoxynucleotides. The ion at m/z 381 corresponds to the loss of H2O from the ion at m/z 399. These results indicated that the B[a]PDE modification was present on the phosphate moiety of the 2′-deoxynucleotide resulting in the formation of a phosphodiester adduct. Further product ions were observed corresponding to m/z 79 [PO3]−, m/z 97 [H2PO4]−, m/z 195 [(2′-deoxyribose+phosphate)−H]− that were common to the spectra for all four adducted 2′-deoxynucleotides. The spectra also contained product ions that correspond to the unadducted 2′-deoxynucleoside 3′-monophosphate and base at m/z 346 [dGp−H]−, m/z 150 [guanine−H]−, m/z 330 [dAp−H]−; m/z 134 [adenine−H]−, 306 [dCp−H]−; m/z 110 [cytosine−H]− and m/z 321 [Tp−H]−; m/z 125 [thymine−H]−. The fragmentation pathway of phosphodiester adducted 2′-deoxynucleotides is shown in Scheme 2. It was noted that there was a complete absence of products ions corresponding to the adducted bases in the spectra.

Reaction of 2′-deoxynucleotides with B[a]PDE—base adducts
For each 2′-deoxynucleotide, the base adducts eluted after the phophodiester adducts following analysis by HPLC-fluorescence and then by LC-ESI-MS/MS CID. Typically, the LC-ESI-MS/MS retention times ranged from 13 to 28 min using the microbore C18 column (data not shown). The LC-ESI-MS/MS CID product ion spectra for each adducted 2′-deoxynucleotide are shown in Figures 2C, 3C and 4C showing adduct formation with the base. Product ions at m/z 452 and 550 were observed resulting from the fragmentation of the B[a]PDE adducted dGp precursor molecular ion at m/z 648 [M−H]− (Figure 2C), corresponding to [(B[a]Ptriol+guanine)−H]− following cleavage of the glycosidic bond and [(B[a]Ptriol+2′-deoxyguanosine)−H]− following loss of one H2O molecule plus the phosphate group, respectively. The ions at m/z 434 and 416 correspond to the loss of one and two H2O molecules from the ion at m/z 452, respectively. Similarly, the ions at m/z 532 and 514 correspond to the loss of one and two H2O molecules from the ion at m/z 550, respectively. These results imply the presence of a B[a]PDE modification on the guanine base of dGp. A product ion at m/z 436 was observed resulting from the fragmentation of the B[a]PDE adducted dAp precursor molecular ion at m/z 632 [M−H] (Figure 3C) corresponding to [(B[a]Ptriol+adenine)−H]− following cleavage of the glycosidic bond. The ions at m/z 418 and 400 correspond to the loss of one and two H2O molecules from the ion at m/z 436, respectively. These results imply the presence of a B[a]PDE modification on the adenine base of dAp. A product ion at m/z 412 was observed resulting from the fragmentation of the B[a]PDE adducted dCp precursor molecular ion at m/z 608 [M−H]− (Figure 4C) corresponding to [(B[a]Ptriol+cytosine)−H]− following cleavage of the glycosidic bond. The ions at m/z 394 and 376 correspond to the loss of one and two H2O molecules from the ion at m/z 412, respectively. These results imply the presence of a B[a]PDE modification on the cytosine base of dCp. The fragmentation pathway of base adducted 2′-deoxynucleotides is shown in Scheme 3. It was noted that there was a complete absence of products ions characteristic of an adducted phosphate group. All three spectra for the base adducted 2′-deoxynucleoside 3′-monophosphates contained a product ion at m/z 283 corresponding to B[a]Pdiol.

Confirmation that the structural identity of the base adducts was due to the reaction of B[a]PDE with the exocyclic –NH2 group was ascertained following analysis by positive ESI. The LC-ESI-MS/MS CID product ion spectra for each base adducted 2′-deoxynucleotide are shown in Figure 6. The spectrum for each base adducted 2′-deoxynucleotide contained common product ions. The ion at m/z 303 corresponds to B[a]Ptriol. The ion at m/z 285 corresponds to B[a]Pdiol following loss of H2O from the ion at m/z 303. The ion observed at m/z 257 corresponds to the loss of CO from the ion at m/z 285. The spectra also contained product ions that correspond to the unadducted 2′-deoxynucleoside 3′-monophosphate and base at m/z 348 [dGp+H2]+; m/z 152 [guanine+H2]+, m/z 332 [dAp+H2]+
m/z 136 [adenine+H2]+, and m/z 308 [dCp+H2]+; m/z 112 [cytosine+H2]+. Product ions were observed corresponding to the adducted base following cleavage of the glycosidic bond at m/z 454 [(B[a]Ptriol+guanine)+H2]+, at m/z 438 [(B[a]Ptriol+adenine)+H2]+ and at m/z 414 [B[a]Ptriol+cytosine+H2]+. No product ions resulting from the neutral loss of 17 u corresponding to NH3 were observed, thus confirming that B[a]PDE adduct formation for each 2′-deoxynucleotides was by reaction with the exocyclic –NH2 group at position N2 for guanine, N6 for adenine and N4 for cytosine.
Figure 6. Typical positive ESI LC-MS/MS CID product ion spectra for the base adducted 2′-deoxynucleotides. The spectra were obtained from the molecular ions [M+H]+ at m/z 650, B[a]PDE plus dGp (fraction 3, Figure 2A) (A), m/z 634 B[a]PDE plus dAp [fraction 4 (×2 concentrated), Figure 3A] (B) and m/z 610 B[a]PDE plus dCp [fraction 4 (×2 concentrated), Figure 4A] (C) following isocratic elution with 0.1% acetic acid/methanol (50:50, v/v) at a flow rate of 120 μl/min. The MS conditions used are as described in the Experimental Procedures section except for the following; capillary voltage, 3.20 kV and collision energy, 16 eV.


Scheme 1. Reaction of B[a]PDE with the sugar phosphate backbone of DNA and postulated mechanism for strand scission [adapted from Gamper et al. (29)].


Scheme 2. Negative ESI-MS/MS CID fragmentation pathway for B[a]PDE 2′-deoxynucleotide phosphodiester adducts.


Scheme 3. Negative ESI-MS/MS CID fragmentation pathway for B[a]PDE base 2′-deoxynucleotides adducts (ions in brackets were not observed).



DISCUSSION
The results of this investigation provide the first direct evidence for the formation of phosphodiester adducts with 2′-deoxynucleotides that are normally present in DNA by the reactive PAH epoxide metabolite, B[a]PDE, thus providing supporting evidence to the supposition that B[a]PDE can react with the sugar-phosphate backbone of DNA resulting in the formation of phosphotriester adducts. Koreeda et al. were the first to provide indirect evidence that B[a]PDE may form phosphotriester adducts as well as base adducts following their experiments involving the reaction of tritium labelled B[a]PDE with polyguanylic acid (4). Chan and Raddo hypothesized that the formation of phosphotriesters from the reaction of B[a]PDE with DNA was chemically feasible using initial model experiments investigating the formation of phosphotriesters following the reaction of cyclohexene oxides with dibenzyl or diethyl phosphates (30). Subsequent experiments by the authors demonstrated that various PAH epoxides as well as B[a]PDE reacted with dibenzyl or diethyl phosphates resulting in the formation of phosphotriester adducts in a regio- and stereo-specific manner as determined by NMR spectroscopy (31). We investigated the reaction of B[a]PDE with 2′-deoxynucleotides, which resulted in the formation of a number of additional early eluting product peaks when compared to a control reaction mixture containing only the B[a]PDE and buffer following HPLC-fluorescence analysis, which were further characterized using LC-ESI-MS/MS CID. The peaks present in the control reaction mixture (Figure 1) represent breakdown products such as B[a]Ptetraols following hydrolysis of the B[a]PDE. The direct HPLC-fluorescence analysis of (±)-anti-B[a]PDE following hydrolysis in aqueous methanol resulted in the detection of two major peaks (corresponding to the peaks labelled with an asterisk in Figure 1) and two later eluting minor peaks (data not shown). We hypothesize that the other later eluting peaks observed may be impurities derived from the interaction of B[a]PDE with the TRIS base reaction buffer. Previous studies have shown that hydrolysis of B[a]PDE in aqueous solutions at neutral pH results in the formation of two B[a]Ptetraol products with trans and cis configurations (32). It was noted that each HPLC fraction analysed contained several product peaks, the reason being that each peak corresponded to the different stereoisomers of adducts resulting from the cis or trans addition at C-10 of the (±)-anti-B[a]PDE (33). The interaction of the (+)- or (−)-anti-enantiomers of B[a]PDE with either 2′-deoxyguanosine or 2′-deoxyadenosine will result in the formation of two pairs of stereoisomer adducts, namely, (+)-anti-trans-, (+)-anti-cis-, (−)-anti-trans- and (−)-anti-cis- following reaction with the exocyclic amino group of the base (34). Furthermore, the phosphate of the phosphotriester group is chiral with adduct formation resulting in two configurations, Rp and Sp (35). Using LC-ESI-MS/MS CID reaction products were differentiated having a unique CID product ion spectra characteristic of a phosphodiester adduct. The presence of product ions at m/z 399 and 497 was observed for all four 2′-deoxynucleotides, corresponding to [(B[a]Ptriol+phosphate)−H]− and [(2′-deoxyribose+phosphate+B[a]Ptriol)−H]−, respectively. There was an absence of product ions in the spectra corresponding to B[a]PDE adducted bases. For the three B[a]PDE and 2′-deoxynucleotide reaction mixtures the phosphodiester adducts eluted before the corresponding base adducts following HPLC-fluorescence analysis. Canella et al. noted the presence of uncharacterized products in their investigation of the synthesis of base adducts by the reaction of B[a]PDE with 2′-deoxynucleotides. Two early eluting products were detected following HPLC-UV analysis of a B[a]PDE plus 2′-deoxyadenosine 5′-monophosphate reaction mixture that were resistant to hydrolysis by alkaline phosphatase unlike the base adducts (36). The identity of these products was not elucidated but it was concluded that their structure contained a nucleotide component that required the presence of 2′-deoxynucleotides in the B[a]PDE reaction mixture for their formation (36). It is feasible to assume that these unidentified products were phosphodiester adducts.

Further reaction products were identified having CID product ion spectra characteristic of adduct formation with the bases of the 2′-deoxynucleotides resulting from cleavage of the glycosidic bond, with prominent product ions at m/z 452, 436 and 412 [(B[a]Ptriol+base)−H]− corresponding to B[a]PDE adducts of guanine, adenine and cytosine, respectively. Consistent with previous reports in the literature B[a]PDE adduct formation with the base was confined to dGp, dAp and dCp (27,37,38). Confirmation that the reaction with exocyclic –NH2 group of each base had occurred was obtained following positive ESI LC-MS/MS analysis of the reaction products. The CID product ion spectra revealed that no product ions resulting from the neutral loss of 17 u corresponding to NH3, were observed. Thus, confirming that B[a]PDE adduct formation for each 2′-deoxynucleotide was by reaction with the exocyclic –NH2 group at position N2 for guanine, N6 for adenine and N4 for cytosine. For example, the CID product ion spectra of N-7 alkyl guanine adducts such as those derived from ethylating agents contain a product ion corresponding to the neutral loss of NH3 from the alkylated [M+H]+ ion (39,40). No base adducts of Tp were detected which is again consistent with previous findings. Due to later elution of the phosphodiester adducts of Tp following HPLC-fluorescence analysis (Figure 5A) compared to the other three 2′-deoxynucleotides, any base adducts formed may have eluted in the region of the hydrolyzed break down products of B[a]DPDE. Studies in vitro have shown that the stereochemistry of B[a]PDE influences the extent of formation of the different base adducts following the reaction with DNA. The (+)-anti-B[a]PDE isomer with the 7R,8S,9S,10R configuration has the highest reactivity resulting in 95% guanine and 5% adenine of total adducts being formed (24,41). The results described in the present study do not allow for the estimation of the extent B[a]PDE adduct formation with the phosphate group relative to the base since the HPLC-fluorescence detector response may be significantly different for the phosphodiester adducts compared to the base adducts.

The formation of B[a]PDE phosphotriester adducts in DNA has the potential for producing more profound adverse biological consequences when compared to the stable alkyl phosphotriesters adducts formed by simple alkylating agents. This is due to the presence of an oxygen atom in the β position with respect to the ester group that can lead to the alteration in the integrity of the DNA via mechanism of internal oxygen nucleophilic displacement at the phosphate atom, resulting in strand scission (29,42). The confirmation of the formation of B[a]PDE phosphodiester adducts should allow for the investigation of methodology for the detection of B[a]PDE phosphotriester adducts in DNA. The first methods developed to detect alkyl phosphotriester adducts in DNA relied on the production of non-specific alkaline hydrolysis-induced strand breaks at the site of the phosphotriester adduct (43). Subsequent approaches to detect alkyl phosphotriester adducts in DNA relied on 32P postlabelling techniques (8,11,44,45). In the last few years, liquid chromatography coupled to mass spectrometry has been increasingly used for not only for the characterization of DNA adducts but also their detection (46). Recently, LC-MS/MS methods have been described for the detection of alkyl phosphotriester adducts in DNA relying on selective enzymatic digestion (47–50). The transalkylation approach involves the alkyl group of the phosphotriester adduct in di-2′-deoxynucleoside monophosphates, formed following enzymatic digestion of DNA, undergoing nucleophilic displacement by cob(I)alamin. The resulting alkyl-cob(I)alamin product can then be determined by LC-MS/MS (47, 48). The enzymatic digestion relies on the presence of a phosphotriester adduct in DNA generating di-2′-deoxynucleoside monophosphate adduct triesters, since the internucleotide bonds adjacent to a completely esterified phosphate group are resistant to enzymatic cleavage by nucleases (48,51). The method described by Haglund et al. uses enzymatic digestion with nuclease P1 in combination with 5′-phosphodiesterase and alkaline phosphatase for the direct detection of di-2′-deoxynucleoside monophosphate ethyl triesters by online column switching LC-MS/MS (48). However, optimization of the enzymatic digestion may be required for the detection of B[a]PDE phosphotriester adducts, since it is found for bulky DNA adducts such as those derived from B[a]PDE, that di-2′-deoxynucleoside monophosphates are generated by the presence of base adducts, which are particularly resistant to enzymatic digestion (52,53). These B[a]PDE di-2′-deoxynucleoside monophosphate adducts have been observed to occur at a 50 times lower level than the main base adduct formed at the exocyclic –NH2 group of guanine in DNA (54).

In conclusion, the formation of phosphodiester adducts following the reaction of B[a]PDE with 2′-deoxynucleotides has been confirmed, having been identified with distinct CID product ion spectra when compared to base adducted 2′-deoxynucleotides.

ACKNOWLEDGEMENTS
The authors gratefully acknowledge the Medical Research Council (grant number G0100873) for financial support. Funding to pay the Open Access publication charges for this article was provided by Medical Research Council UK.

Conflict of interest statement. None declared.
==== Refs
REFERENCES
1 Bannon P  Verly W   Alkylation of phosphates and stability of phosphate triesters in DNA Eur. J. Biochem 1972 31 103 111 4344908 
2 Shooter KV   DNA phosphotriesters as indicators of cumulative carcinogen induced damage Nature 1978 274 612 614 672995 
3 Beranek DT   Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents Mutat. Res 1990 231 11 30 2195323 
4 Koreeda M  Moore PD  Yagi H  Yeh HJC  Jerina DM   Alkylation of polyguanylic acid at the 2-amino group and phosphate by the potent mutagen (±)-7β,8α-dihydroxy-9β, 10β-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene J. Am. Chem. Soc 1976 98 6720 6722 972227 
5 Shooter KV  Slade TA   The stability of methyl and ethyl phosphotriesters in DNA in vivo  Chem. Biol. Interact 1977 19 353 361 597965 
6 Bodell WJ  Singer B  Thomas GH  Cleaver JE   Evidence for removal at different rates of O-ethyl pyrimidines and ethylphosphotriesters in two human fibroblast cell lines Nucleic Acids Res 1979 6 2819 2829 223129 
7 Den Engelse L  De Graaf A  De Brij R-J  Menkveld GJ   O2 - and O4 -ethylthymine and the ethylphosphotriester dTp(Et)dT are highly persistent DNA modifications in slowly dividing tissue of the ethylnitrosourea-treated rat Carcinogenesis 1987 8 751 757 3608071 
8 Guichard Y  Jones GDD  Farmer PB   Detection of DNA alkylphosphotriesters by 32 P postlabeling: evidence for the nonrandom manifestation of phosphotriester lesions in vivo  Cancer Res 2000 60 1276 1282 10728687 
9 Tsujikawa L  Weinfeld M  Reha-Krantz LJ   Differences in replication of a DNA template containing an ethyl phosphotriester by T4 DNA polymerase and Escherichia coli  DNA polymerase I Nucleic Acids Res 2003 31 4965 4972 12930945 
10 Lawley PD   Reaction of N -methyl-N -nitrosourea (MNUA) with 32 P-labelled DNA: evidence for formation of phosphotriesters Chem. Biol. Interact 1973 7 127 130 4588104 
11 Singh R  Sweetman GMA  Farmer PB  Shuker DEG  Rich KJ   Detection and characterization of two major ethylated deoxyguanosine adducts by high performance liquid chromatography, electrospray mass spectrometry, and 32 P-postlabeling. Development of an approach for detection of phosphotriesters Chem. Res. Toxicol 1997 10 70 77 9074805 
12 Yates JM  Fennell TR  Turner MJ  Recio L  Sumner SCJ   Characterization of phosphodiester adducts produced by the reaction of cyanoethylene oxide with nucleotides Carcinogenesis 1994 15 277 283 8313518 
13 Maccubbin AE  Caballes L  Riordan JM  Huang DH  Gurtoo HL   A cyclophosphamide/DNA phosphoester adduct formed in vitro  and in vivo  Cancer Res 1991 51 886 892 1988129 
14 Deforce DLD  Ryniers FPK  Van den Eeckhout EG  Lemiere F  Esmans EL   Analysis of DNA adducts in DNA hydrolysates by capillary zone electrophoresis-electrospray mass spectrometry Anal. Chem 1996 68 3575 3584 8928934 
15 Deforce DLD  Lemiere F  Esmans EL  De Leenheer A  Van den Eeckhout EG   Analysis of the DNA damage induced by phenyl glycidyl ether using capillary zone electrophoresis-electrospray mass spectrometry Anal. Biochem 1998 258 331 338 9570849 
16 Deforce DLD  Lemiere F  Hoes I  Millecamps REM  Esmans EL  De Leenheer A  Van den Eeckhout EG   Analysis of the DNA adducts of phenyl glycidyl ether in a calf thymus DNA hydrolysate by capillary zone electrophoresis-electrospray mass spectrometry: evidence for phosphate alkylation Carcinogenesis 1998 19 1077 1086 9667747 
17 Phillips DH   Fifty years of benzo[a]pyrene Nature 1983 303 468 472 6304528 
18 Schoket B   DNA damage in humans exposed to environmental and dietary polycyclic aromatic hydrocarbons Mutat. Res 1999 424 143 153 10064857 
19 Bostrom C-E  Gerde P  Hanberg A  Jernstrom B  Johansson C  Kyrklund T  Rannug A  Tornqvist M  Victorin K  Westerholm R   Cancer risk assessment, indicators and guidelines for polycyclic aromatic hydrocarbons in the ambient air Environ. Health Perspect 2002 110 Suppl. 3 451 488 12060843 
20 Ross JA  Nelson GB  Wilson KH  Rabinowitz JR  Galati A  Stoner GD  Nesnow S  Mass MJ   Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels Cancer Res 1995 55 1039 1044 7866986 
21 Boffetta P  Jourenkova N  Gustavsson P   Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons Cancer Causes Control 1997 8 444 472 9498904 
22 Kriek E  Rojas M  Alexandrov K  Bartsch H   Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk Mutat. Res 1998 400 215 231 9685648 
23 Baird WM  Hooven LA  Mahadevan B   Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action Environ. Mol. Mutagen 2005 45 106 114 15688365 
24 Xue W  Warshawsky D   Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review Toxicol. Appl. Pharmacol 2005 206 73 93 15963346 
25 Geacintov NE  Hibshoosh H  Ibanez V  Benjamin MJ  Harvey RG   Mechanisms of reaction of benzo[a]pyrene-7,8-diol-9,10-epoxide with DNA in aqueous solutions Biophys. Chem 1984 20 121 133 6435696 
26 Straub KM  Meehan T  Burlingame AL  Calvin M   Identification of the major adducts formed by reaction of benzo[a]pyrene diol epoxide with DNA in vitro  Proc. Natl Acad. Sci. USA 1977 74 5285 5289 271953 
27 Willems AV  Deforce DL  Van Den Eeckhout EG  Lambert WE  Van Peteghem CH  De Leenheer AP  Van Bocxlaer JF   Analysis of benzo[a]pyrene diol epoxide-DNA adducts by capillary zone electrophoresis-electrospray ionization-mass spectrometry in conjunction with sample stacking Electrophoresis 2002 23 4092 4103 12481265 
28 Buening MK  Wislocki PG  Levin W  Yagi H  Thakker DR  Akagi H  Koreeda M  Jerina DM  Conney AH   Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene Proc. Natl Acad. Sci. USA 1978 75 5358 5361 281685 
29 Gamper HB  Tung ASC  Straub K  Bartholomew JC  Calvin M   DNA strand scission by benzo[a]pyrene diol epoxides Science 1977 197 671 674 877583 
30 Chan TH  Di Raddo P   Reaction of cyclohexene oxides with phosphodiesters – towards understanding the reaction of benzo[a]pyrene diol epoxide with DNA Tetrahedron Lett 1979 20 1947 1950 
31 Di Raddo P  Chan T-K   Reactions of phosphodiesters with epoxides of polycyclic aromatic hydrocarbons J. Chem. Soc. Chem. Commun 1983 1 16 17 
32 Doan L  Lin B  Yagi H  Jerina DM  Whalen DL   New insights on the mechanisms of the pH-independent reactions of benzo[a]pyrene 7,8-diol 9,10-epoxides J. Am. Chem. Soc 2001 123 6785 6791 11448182 
33 Peltonen K  Canella K  Dipple A   High-performance liquid chromatographic separation of purine deoxyribonucleoside monophosphate-benzo[a]pyrene adducts J. Chromatogr 1992 623 247 254 1460077 
34 Cheng SC  Hilton BD  Roman JM  Dipple A   DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide Chem. Res. Toxicol 1989 2 334 340 2519824 
35 Weinfeld M  Drake AF  Kuroda R  Livingston DC   Isolation and characterization of the diastereoisomers of a series of phosphate-ethylated dinucleoside monophosphates Anal. Biochem 1989 178 93 101 2729585 
36 Canella K  Peltonen K  Dipple A   Identification of (+) and (−) anti  benzo[a]pyrene dihydrodiol epoxide-nucleic acid adducts by the 32 P-postlabeling assay Carcinogenesis 1991 12 1109 1114 1904321 
37 Meehan T  Straub K  Calvin M   Benzo[a]pyrene diol epoxide covalently binds to deoxyguanosine and deoxyadenosine in DNA Nature 1977 269 725 727 304179 
38 Wang JJ  Marshall WD  Law B  Lewis DM   Fragmentation patterns of DNA-benzo[a]pyrene diol epoxide adducts characterized by nanoflow LC/quadrupole time-of-flight mass spectrometry Int. J. Mass Spectrom 2003 230 45 55 
39 Singh R  Kaur B  Farmer PB   Detection of DNA damage derived from a direct acting ethylating agent present in cigarette smoke by use of liquid chromatography-tandem mass spectrometry Chem. Res. Toxicol 2005 18 249 256 15720129 
40 Chao M-R  Wang C-J  Yen C-C  Yang H-H  Lu Y-C  Chang LW  Hu C-W   Simultaneous determination of N7 -alkylguanines in DNA by isotope-dilution LC-tandem MS coupled with automated solid-phase extraction and its application to a small fish model Biochem. J 2007 402 483 490 17134374 
41 Meehan T  Straub K   Double-stranded DNA stereoselectivity binds benzo[a]pyrene diol epoxides Nature 1979 277 410 412 551262 
42 Conrad J  Muller N  Eisenbrand G   Studies on the stability of trialkyl phosphates and di-(2′-deoxythymidine) phosphotriesters in alkaline and neutral solution. A model for hydrolysis of phosphotriesters in DNA and on the influence of a β-hydroxyethyl ester group Chem. Biol. Interact 1986 60 57 65 3779884 
43 Shooter KV  Merrifield RK   An assay for phosphotriester formation in the reaction of alkylating agents with deoxyribosenucleic acid in vitro  and in vivo  Chem. Biol. Interact 1976 13 223 236 178454 
44 Saris CP  Damman SJ  Van den Ende AMC  Westra JG  Den Engelse L   A 32 P-postlabelling assay for the detection of alkylphosphotriesters in DNA Carcinogenesis 1995 16 1543 1548 7614687 
45 Le Pla RC  Guichard Y  Bowman KJ  Gaskell M  Farmer PB  Jones GDD   Further development of 32 P-postlabeling for the detection of alkylphosphotriesters: evidence for the long-term non-random persistence of ethyl-phosphotriester adducts in vivo Chem. Res. Toxicol 2004 17 1491 1500 15540947 
46 Singh R  Farmer PB   Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection Carcinogenesis 2006 27 178 196 16272169 
47 Haglund J  Rafiq A  Ehrenberg L  Golding BT  Tornqvist M   Transalkylation of phosphotriesters using cob(I)alamin: toward specific determination of DNA-phosphate adducts Chem. Res. Toxicol 2000 13 253 256 10775324 
48 Haglund J  Van Dongen W  Lemiere F  Esmans EL   Analysis of DNA-phosphate adducts in vitro using miniaturized LC-ESI-MS/MS and column switching: phosphotriesters and alkyl cobalamins J. Am. Soc. Mass Spectrom 2004 15 593 606 15047064 
49 Zhang F  Bartels MJ  Pottenger LH  Gollapudi BB  Schisler MR   Quantitation of DNA adduct of thymidylyl(3′-5′)thymidine methyl phosphotriester by liquid chromatography/negative electrospray tandem mass spectrometry Rapid Commun. Mass Spectrom 2005 19 2767 2772 16134230 
50 Zhang F  Bartels MJ  Pottenger LH  Gollapudi BB  Schisler MR   Quantitation of lower levels of the DNA adduct of thymidylyl(3′-5′)thymidine methyl phosphotriester by liquid chromatography/negative atmospheric pressure chemical ionization tandem mass spectrometry Rapid Commun. Mass Spectrom 2007 21 1043 1048 17310469 
51 Miller PS  Fang KN  Kondo NS  Ts’o POP   Syntheses and properties of adenine and thymine nucleoside alkyl phosphotriesters, the neutral analogs of dinucleoside monophosphates J. Am. Chem. Soc 1971 93 6657 6665 5122782 
52 Ilankumaran P  Pannell LK  Gebreselassie P  Pilcher AS  Yagi H  Sayer JM  Jerina DM   Patterns of resistance to exonuclease digestion of oligonucleotides containing polycyclic aromatic hydrocarbon diol epoxide adducts at N 6  of deoxyadenosine Chem. Res. Toxicol 2001 14 1330 1338 11559050 
53 Tretyakova N  Matter B  Jones R  Shallop A   Formation of benzo[a]pyrene diol epoxide-DNA adducts at specific guanines within K-ras  and p53  gene sequences: stable isotope-labeling mass spectrometry approach Biochemistry 2002 41 9535 9544 12135376 
54 Barry JP  Norwood C  Vouros P   Detection and identification of benzo[a]pyrene diol epoxide adducts to DNA utilizing capillary electrophoresis-electrospray mass spectrometry Anal. Chem 1996 68 1432 1438 8651502

